Table 3 Positive rates of the panel, clinical indicators and the combination of panel and clinical indicators.
From: Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer
Indicator | N | Positive (%) | P* | P** |
---|---|---|---|---|
Panel | 198 | 110 (55.56) | Â | Â |
CA125 | 134 | 85 (63.43) | 0.366 | Â |
HE4 | 89 | 29 (32.58) | 0.004 | Â |
CA125 + HE4 | 89 | 53 (59.55) | 0.652 |  |
ROMA | 87 | 42 (48.28) | 0.533 | Â |
Panel + CA125 | 134 | 111 (82.84) |  < 0.001 |  < 0.001 |
Panel + HE4 | 89 | 61 (68.54) |  < 0.001 |  < 0.001 |
Panel + CA125 + HE4 | 89 | 73 (82.02) |  < 0.001 |  < 0.001 |
Panel + ROMA | 87 | 65 (74.71) |  < 0.001 |  < 0.001 |